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Naive (precursor) CD4+ helper T cells recognize specific
major histocompatibility complex (MHC)–peptide combi-
nations on antigen-presenting cells (APCs) via interactions
with the T-cell receptor (TCR), thereby providing the
first signal required for activation. The second, costimula-
tory signal, is provided by accessory molecules expressed
on APCs, such as the widely studied B7 family of proteins.
B7 proteins are the ligands for the CD28 and CTLA-4 co-
stimulatory molecules that are expressed on T cells. The
combination of these two signals induces interleukin-2
(IL-2) synthesis and secretion, IL-2 receptor expression,
clonal expansion and differentiation of precursor CD4+ T
cells into effector T helper (Th) cells.
Two subsets of effector Th cells have been defined on the
basis of their distinct cytokine secretion patterns and their
immunomodulatory effects: Th1 cells produce inflammatory
cytokines, such as tumor necrosis factor β (TNF-β) and
interferon-γ (IFN-γ), and enhance cellular immunity; Th2
cells produce a different group of cytokines — IL-4, IL-5,
IL-6, IL-10 and IL-13 — and help B cells secrete antibod-
ies. The differentiation of naive T cells into the Th1 or Th2
phenotype has important biological implications in terms of
susceptibility or resistance to a particular disease.
The Th1/Th2 differentiation step requires new protein
synthesis and gene expression. An understanding of the
transcriptional mechanisms that are involved in the differ-
entiation and/or activation of Th1 and Th2 cells might
therefore provide potential targets for therapeutic inter-
vention. In this commentary, we will summarize the tran-
scription factors that have been implicated in this process.
Th1 or Th2 — a multifactorial decision
The selective differentiation of precursor CD4+ T cells
into Th1 and Th2 cells is established during the initial
priming of these cells and is influenced by a variety of
extracellular factors, one of which is the dose of antigen
during priming [1]. Several lines of evidence indicate that
the source of costimulation is another critical factor in the
Th1/Th2 differentiation process. The two members of the
B7 family, B7.1 and B7.2, can be differentially expressed
on dendritic cells, Langerhans cells, activated mono-
cytes, T cells and B cells. Recently, B7.1 and B7.2 have
been described to play distinct roles in the differentia-
tion of Th1 and Th2 cells, although their specific func-
tions remain unclear [2].
The most effective inducer of differentiation is the cyto-
kine environment present during the priming of the pre-
cursor cells. Thus, the presence of IL-4 promotes dif-
ferentiation into Th2 cells, whereas IL-12 and IFN-γ
drive precursor Th cells to differentiate into Th1 cells
[3]. IL-12 is secreted by APCs — mainly macrophages
and dendritic cells — but the source of the initial pro-
duction of IL-4 that triggers differentiation remains
unclear. Recently, APC-derived IL-6 was found to polar-
ize naive CD4+ T cells into Th2 cells by inducing the
initial production of IL-4 in CD4+ T cells [4]. Moreover,
an increased Th1 response and a reduced Th2 response
to Borrelia burgdorferi infection was observed in IL-6-
deficient mice (J. Anguita, M.R., S. Santana. S.W.
Berthold, R.A.F. and E. Fikrig, unpublished observa-
tions). The balance between IL-6 and IL-12 production
by APC therefore plays a critical role in the control of
Th1 and Th2 responses. Additional mechanisms are
important for the Th2 responses: IL-7 also primes
human naive CD4+ T cells for IL-4 production [5].
The overall relevance and relative contribution of each of
these components in the differentiation process remains
controversial; however, as all components are derived from
APCs, their activation events are central to the differentia-
tion of Th1 and Th2 cells. Thus, a simple model of differ-
entiation might include all these elements if the Th1/Th2
decision is the result of a bidirectional communication
between the CD4+ T cells and APCs. The expression of
specific cytokine genes in APCs could be determined by
the intracellular signals provided by MHC class II (upon
interaction with antigen), B7.1 or B7.2 (upon ligation with
CD28 or CTLA-4), CD40 (upon interaction with the CD40
ligand) and other potential costimulatory molecules. This
cytokine environment would then modulate the polariza-
tion of the T-cell component. It is therefore important to
determine not only the signaling pathways and transcrip-
tional mechanisms that control the expression of IL-4 and
IFN-γ during the differentiation of Th1 and Th2 cells, but
also the signaling pathways and transcriptional mecha-
nisms that lead to the expression of specific cytokines in
the APCs.
Transcriptional regulation mechanisms in Th1 and Th2
CD4+ T cells
It remains unclear how the interplay between the TCR
complex, costimulatory molecules and cytokine-mediated
signals induces or represses the expression of specific
cytokine genes in CD4+ T cells during Th1/Th2 differen-
tiation. However, numerous studies have focused on the
identification and characterization of specific transcription
factors that are expressed exclusively in either of these
T-cell subsets.
STAT4 and STAT6 transcription factors are induced
upon tyrosine phosphorylation triggered by IL-12 and
IL-4 stimulation, respectively. To date, no other cyto-
kine has been able to induce STAT4, and only IL-13 in
addition to IL-4 can trigger the phosphorylation and
translocation of STAT6. The development of Th1 cells
in response to either IL-12 or Listeria monocytogenes infec-
tion is impaired in STAT4-deficient mice [6,7]. Simi-
larly, as expected, an impairment of IL-4-mediated Th2
responses was observed in STAT6-deficient mice [6,8,9].
Nevertheless, direct regulation of IFN-γ and IL-4 gene
expression by STAT4 or STAT6, respectively, has not
been demonstrated. No functional STAT6-binding sites
have yet been identified in the promoter region of the
IL-4 gene. It is, however, intriguing that IL-4 receptor
expression is not upregulated in response to IL-4 in
STAT6-deficient mice [6], suggesting that STAT6 may
also be involved in controlling the expression of the IL-4
receptor gene. Recently, a STAT6 binding site has been
found to negatively regulate a Th1-specific IL-4 silencer
[10]. No functional STAT4-binding site has yet been
found in the promoter of IFN-γ gene.
The proto-oncogene c-maf has also been identified as a
potent transactivator of the IL-4 promoter [11], and is
expressed in Th2 clones, but not in Th1 clones. Low
levels of c-maf are expressed in naive T cells, suggesting
that it may play a role in the initial activation of IL-4 gene
expression. Levels of c-maf expression are then greatly
upregulated upon Th2 differentiation. These kinetics of
expression suggest that c-maf might be responsible for the
high levels of IL-4 produced by fully differentiated Th2
cells upon restimulation (as in Th2 clones). Additional
factors might be involved in the regulation of the initial
expression of the IL-4 gene during the differentiation of
Th2 cells. 
More recently, it has been shown that GATA-3, a transcrip-
tion factor required for T-cell development, is expressed at
a high level in naive CD4+ T cells and Th2 cells, but at a
low level in Th1 cells [12]. As developing Th1 effector
cells commit to the prototypic lineage, they suppress
GATA-3 expression. In Th2 clones, antisense GATA-3
inhibits the expression of IL-4, IL-6, IL-10 and IL-13
and, to a lesser extent, IL-5. Furthermore, overexpression
of GATA-3 in transgenic mice results in sustained expres-
sion of IL-4, IL-6 and IL-10 genes in Th1 cells and
GATA-3 directly transactivates the IL-4 [12] and IL-5 [13]
promoters. Together, these studies suggest that GATA-3
plays a key role in promoting Th2 differentiation, and, as a
result, GATA-3 expression is suppressed in developing
Th1 cells [12].
The activator protein-1 (AP-1) and nuclear factor of acti-
vated T cells (NFAT) families of transcription factors are
involved in the expression of IL-2, IL-4 and other cytokine
genes. We have shown that AP-1 and NFAT are highly
transcriptionally active in Th2 cells, whereas only low
levels of AP-1 and NFAT transcriptional activity are
detectable in Th1 cells [14,15]. These results correlate
with the overexpression of JunB in the Th2 subset, sug-
gesting that JunB might play a role in the activation of the
Th2 cells. However, hyperproliferation and increased Th2
responses in vivo to Leishmania major infection have been
reported in mice deficient for NFAT1 (NFATp), one of
the members of the NFAT family [16,17]. In contrast, a
reduction in the initial production of IL-4 and other 
Th2 cytokines has also been observed after in vitro TCR
ligation on T cells from these mice [18], supporting the
role of NFAT in the regulation of Th2-specific cytokine
genes. As NFAT now comprises a large family of related
transcription factors, it is possible that other members of
the NFAT family compensate for the lack of NFAT1.
Although we could not demonstrate differences in the
NFAT complexes that might have explained the selec-
tive activation of NFAT in Th2 cells [15], E. Serfling
and S. Chuvipilo (personal communication) have recently
observed a distinct longer nuclear persistence of NFAT1
in Th2 cells. As the differences in NFAT and AP-1 are
found in Th1 and Th2 effector cells, and not during the
priming/differentiation phase, it is likely that the key role
of these factors is in the production of effector cytokines,
not the determination of the T-helper phenotype [14].
Another factor, nuclear factor (NF)-IL6, is expressed 
in mouse Th2 clones, but not in Th1 clones, and
enhances IL-4 promoter activity [19]. NF-IL6 was origi-
nally described to be induced by IL-6, suggesting an
attractive hypothesis to explain its role. Further studies
are needed, however, to test the role of NF-IL6 as a medi-
ator of the IL-6-induced differentiation of Th2 cells.
The above data indicate that the control of the Th1/Th2
polarization is achieved by multiple transcription factors
with several checkpoints during differentiation and acti-
vation of the effector cells (Figure 1). Nevertheless, most
of these transcription factors are involved in late stages of
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differentiation or during initial activation. An under-
standing of the transcriptional mechanisms that control
the earliest events in the differentiation of naive CD4+ T
cells as well as the expression of the polarizing factors
remains incomplete.
Transcriptional regulation in the APC: the other side of 
the mirror
It is essential to dissect not only the molecular bases for
the regulation of cytokine genes in the CD4+ T cells, but
also the regulation of the genes expressed in the APCs
(Figure 1). Recent studies from two different groups have
revealed a role for another transcription factor, the inter-
feron regulatory factor 1 (IRF-1), in the control of the
development of Th1 responses by affecting the cytokine
production in APCs [20,21].
IRF-1 was originally described as a protein that binds to
DNA sequences in the promoters of the IFN-α and
IFN-β genes, although it was also reported that IRF-1 is
involved in the regulation of several genes that are
inducible by IFN-α/β and IFN-γ [22]. Compared with
normal mice, IRF-1-deficient mice are less resistant to
infection with encephalomyocarditis virus, but not to
infection by other viruses [23,24]. In addition, develop-
ment of CD8+ T cells and expression of the nitric oxide
synthase gene are also impaired in these mice. Taki et al.
[21] and Lohoff et al. [20] found that the absence of IRF-1
expression strongly blocks the development of a Th1
response. In vivo studies of IRF-1-deficient mice showed
a decrease in IFN-γ production and an enhanced disease
susceptibility in response to L. major infection [20]. IRF-
1-deficient mice were also more susceptible to L. mono-
cytogenes infection, but showed highly efficient expulsion
of Nippostrongylus brasiliensis, a phenomenon associated
with an increase in the Th2 response [21]. 
As is the case with STAT4, however, no binding site for
IRF-1 has been reported in the promoter of the IFN-γ
gene, suggesting that IRF-1 does not directly upregulate
the expression of the IFN-γ gene. In fact, enhanced IFN-γ
production has been previously observed in CD8+ T cells
from IRF-1-deficient mice. Interestingly, Lohoff et al.
[20] have identified a profound defect in IL-12 production
by macrophages in infected IRF-1-deficient mice upon re-
stimulation with lipopolysaccharide (LPS), indicating that
a lack of secretion of IL-12 by APCs could be the primary
factor that promotes Th2 development. Similar results
were obtained in the studies of Taki et al. [21]: IL-12p40
mRNA was highly induced in wild-type peritoneal macro-
phages upon LPS treatment, whereas no IL-12p40 message
could be detected in activated macrophages from IRF-1-
deficient mice. It was previously shown that IL-12p40 is a
target for IRF-1 and that IRF-1 in combination with
NFκB can co-operate to mediate transcription of the 
IL-12p40 gene [25]. Together, these results highlight the
importance of studying the cytokines or other molecules
expressed in APCs that are involved in the differentiation
process as well as the cytokine genes expressed during the
activation of Th1 or Th2 cells.
Figure 1
Transcriptional checkpoints in the
differentiation of Th1 and Th2 cells. The
transcriptional control of Th1/Th2
differentiation occurs at both sides of the
mirror: T cells and antigen-presenting cells
(APC). The relative expression of the
transcription factors is represented by the size
of the font; question marks indicate the results
to be tested; asterisks indicate high
transcriptional activity. 
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These two reports differ in their conclusions regarding the
relevance of IRF-1 in CD4+ T cells. By transferring IRF-1-
deficient CD4+ T cells into RAG-deficient mice, Lohoff et
al. [20] showed that IRF-1-deficient CD4+ T cells can
mount a normal Th1 response and clear L. major infections,
suggesting that APCs are responsible for the Th2 pheno-
type in IRF-1-deficient mice. In contrast, Taki et al. [21]
revealed that IRF-1-deficient CD4+ T cells were hypore-
sponsive to IL-12 in vitro, although no significant differ-
ences in the expression of IL-12 receptor β1 and β2
genes between wild-type and IRF-1-deficient mice were
observed. It is possible that this discrepancy between the
two studies is due to the in vivo versus in vitro systems used.
Genetic background is another important factor that
affects the resistance and susceptibility to a particular
disease. Mice with a resistant genetic background — such
as C57BL/6 — develop a Th1 response during infection
with L. major that can clear the parasite rapidly. In con-
trast, susceptible mice — BALB/c — develop a L. major-
specific Th2 response that results in the visceralization of
the disease and rapid death. The identification of the dif-
ferences between the two genetic backgrounds has been
the goal of numerous studies. Recently, a locus on murine
chromosome 11 has been identified that controls the
maintenance of IL-12 responsiveness and, therefore, the
subsequent Th1/Th2 response [26]. Several genes related
to the immune response have been found in that locus
including, interestingly, the murine IRF-1 gene.
Not surprisingly, perhaps, the intense study of transcrip-
tional regulation during Th1/Th2 differentiation has led to
the elucidation of multiple transcription factors that are
involved in regulating this process. This regulation occurs
in response to numerous environmental factors that directly
or indirectly influence the decision of a naive CD4+ T cell
to become a Th1 or Th2 effector cell. Transcriptional
events within the CD4+ T cells themselves, as well as in
the APCs, are critical to this decision, and both cell types
form attractive targets for therapeutic intervention in the
balance between Th1 and Th2 immune responses.
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